Levels of GFAP Higher in NMOSD, Suggesting It May Serve as a Biomarker
May 28th 2020A subset group of inebilizumab-treated patients who did not have adjudicated attacks displayed more than a 2-fold increase in serum CSF glial fibrillary acidic protein from baseline, implying GFAP may serve as a biomarker.
Shadi Yaghi, MD: Incidence of Stroke in Patients With COVID-19
May 28th 2020The assistant professor and director of Clinical Vascular Neurology Research at NYU Langone gives perspective on his recent study of patients with stroke and COVID-19 and the difficulties in understanding their relationship.